Circulating microRNA-21 is an early predictor of ROS-mediated damage in subjects with high risk of developing diabetes and in drug-naïve T2D.
Lucia La SalaSimona Mrakic-SpostaElena TagliabueFrancesco PrattichizzoStefano MicheloniElena SangalliClaudia SpecchiaAnna Chiara UccellatoreSilvia LupiniGaia SpinettiPaola de CandiaAntonio CerielloPublished in: Cardiovascular diabetology (2019)
our data demonstrate that microRNA-21 is associated with prediabetic status and exhibits predictive value for early detection of glucose imbalances. These data could provide novel clues for miR-based biomarkers to evaluate diabetes.